CR10003A - SULFAMOIL SULFONATE PRODUCTS - Google Patents

SULFAMOIL SULFONATE PRODUCTS

Info

Publication number
CR10003A
CR10003A CR10003A CR10003A CR10003A CR 10003 A CR10003 A CR 10003A CR 10003 A CR10003 A CR 10003A CR 10003 A CR10003 A CR 10003A CR 10003 A CR10003 A CR 10003A
Authority
CR
Costa Rica
Prior art keywords
sulfamoil
production
sulfonate products
sulfonate
products
Prior art date
Application number
CR10003A
Other languages
Spanish (es)
Inventor
Ralf Wyrwa
Reinhard Nubbemeyer
Ursula Ganzer
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of CR10003A publication Critical patent/CR10003A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Esta invención se relaciona con prodrogas de sulfonato de sulfamoilo de fórmula general I, con un proceso para su producción, con composiciones farmacéuticas que contienen estos compuestos, y con su uso para la producción de agentes farmacéuticos disponibles por vía oral. Los compuestos de acuerdo a la invención se unen a anhidrasas carbónicas e inhiben a estas enzimas.This invention relates to sulfamoyl sulfonate prodrugs of general formula I, a process for their production, pharmaceutical compositions containing these compounds, and their use for the production of orally available pharmaceutical agents. The compounds according to the invention bind carbonic anhydrases and inhibit these enzymes.

CR10003A 2005-11-30 2008-05-21 SULFAMOIL SULFONATE PRODUCTS CR10003A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005057408A DE102005057408A1 (en) 2005-11-30 2005-11-30 New sulfamoylsulfonate prodrugs e.g. useful for protecting red blood cells from attack by parasites or for hormone replacement therapy, female fertility control or treating hormone-associated diseases

Publications (1)

Publication Number Publication Date
CR10003A true CR10003A (en) 2008-08-21

Family

ID=37983623

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10003A CR10003A (en) 2005-11-30 2008-05-21 SULFAMOIL SULFONATE PRODUCTS

Country Status (15)

Country Link
EP (1) EP1957513A2 (en)
JP (1) JP2009517424A (en)
KR (1) KR20080072956A (en)
CN (1) CN101316858A (en)
AU (1) AU2006319380A1 (en)
BR (1) BRPI0619253A2 (en)
CA (1) CA2632272A1 (en)
CR (1) CR10003A (en)
DE (1) DE102005057408A1 (en)
EA (1) EA200801306A1 (en)
EC (1) ECSP088489A (en)
IL (1) IL191570A0 (en)
NO (1) NO20082915L (en)
WO (1) WO2007062874A2 (en)
ZA (1) ZA200805659B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8293783B2 (en) * 2009-03-24 2012-10-23 National University Of Singapore Use of artemisinin derivatives for the treatment of asthma and chronic obstructive pulmonary disease (COPD)
CN101987104A (en) * 2009-08-05 2011-03-23 天津金耀集团有限公司 Ophthalmic composition of heteroaryl sulfamoyl carboxylic ester carbonic anhydrase inhibitor
CN101987101A (en) * 2009-08-05 2011-03-23 天津金耀集团有限公司 Anti-inflammatory eye composition with glucocorticoid aromatic sulfamoyl sulfonic acid ester as active ingredient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (en) * 2000-05-31 2001-12-13 Jenapharm Gmbh Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds
DE102004025966A1 (en) * 2004-05-21 2005-12-15 Schering Ag Estradiol prodrugs
DE102004025985A1 (en) * 2004-05-21 2005-12-15 Schering Ag Estriol and estetrol prodrugs
DE102004025986A1 (en) * 2004-05-21 2005-12-15 Schering Ag Steroid prodrugs with androgenic effects

Also Published As

Publication number Publication date
ECSP088489A (en) 2008-06-30
WO2007062874B1 (en) 2007-09-27
CN101316858A (en) 2008-12-03
EP1957513A2 (en) 2008-08-20
CA2632272A1 (en) 2007-06-07
KR20080072956A (en) 2008-08-07
AU2006319380A1 (en) 2007-06-07
WO2007062874A3 (en) 2007-07-12
JP2009517424A (en) 2009-04-30
WO2007062874A2 (en) 2007-06-07
ZA200805659B (en) 2009-10-28
EA200801306A1 (en) 2008-10-30
IL191570A0 (en) 2008-12-29
DE102005057408A1 (en) 2007-05-31
BRPI0619253A2 (en) 2011-09-27
NO20082915L (en) 2008-06-27

Similar Documents

Publication Publication Date Title
PA8693101A1 (en) ISOINDOL-IMIDA COMPOUNDS AND COMPOSITIONS THAT INCLUDE THEM AND METHODS FOR USE
UY28747A1 (en) NEW PROCESS FOR SYNTHESIS AND NEW CRYSTAL FORM OF AGOMELATINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ECSP099044A (en) FUSIONED PYRIMID COMPOUNDS
CU20090070A7 (en) NEW DERIVATIVES OF SULFONAMIDE AS ANTAGONISTS OF BRADIQUININA
UY29530A1 (en) CHEMICAL COMPOUNDS
UY29919A1 (en) SUBSTITUTED DERIVATIVES OF 3,4-DIHYDROISOQUINOLIN-1-AMINO-TRIFLUOROACETATE, ITS PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS
CR10479A (en) VR1 BENCIMIDAZOLIC MODULARS
UY29479A1 (en) PK-DNA INHIBITORS
CR10696A (en) ISOINDOL N-METHYLAMINE COMPOUNDS, COMPOSITIONS THAT INCLUDE THEM AND METHODS USING THE SAME
PA8796201A1 (en) ANTI-INFECTIVE AGENTS AND THEIR USE
CR8753A (en) DERIVATIVES OF TETRAAZABENZO [E] AZULENO AND ITS ANALOGS
BRPI0607455A2 (en) compound, process for preparing same, use of a compound, and pharmaceutical composition
UY30748A1 (en) NEW COMPOUNDS
UY30025A1 (en) SUBSTITUTED DERIVATIVES OF 2-AMINO-5,6-DIHIDRO PIRIMIDIN-4 (3H) -ONAS AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING AND APPLICATIONS.
CR9507A (en) SULFONAMIDS OF DIARISULFONA AND ITS USES
HN2008000088A (en) HETEROCICLICOS OF 1,4-DIHIDROPIRIDINA- FUSIONADA, PROCESSES TO PREPARE THE SAME, ITS USE AND THE COMPOSITIONS THAT CONTAIN THEM.
CR10557A (en) BENCILAMINS, A PROCESS FOR PRODUCTION AND ITS USE AS ANTI-INFLAMMATORY AGENTS
BRPI0712889A8 (en) compound, process for the preparation of a compound, intermediate compound, and, pharmaceutical composition.
PT2210872T (en) A NEW CRYSTALLINE III FORM OF AGOMELATIN, A PROCESS FOR PREPARING ITSELF AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
CR9391A (en) DERIVATIVES OF INDANIL-PIPERAZINAS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ECSP099389A (en) NEW CRYSTAL FORMS
UY29607A1 (en) CHEMICAL COMPOUNDS
AR058348A1 (en) DERIVATIVES OF 1-AZA-BICYCLE-NONANE AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM
CR11873A (en) NEW HETEROCICLIC CARBOXAMIDS FOR USE AS THROMBIN INHIBITORS
CR10003A (en) SULFAMOIL SULFONATE PRODUCTS

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)